Literature DB >> 19695909

Successful endovascular repair of acute type B aortic dissection in undiagnosed Ehlers-Danlos syndrome type IV.

Z Khalique1, O T A Lyons, R E Clough, R E Bell, J F Reidy, U Schwarze, P H Byers, P R Taylor.   

Abstract

A 61-year-old man presented with an acute type B aortic dissection for which a stent-graft was introduced. He remains complication-free 4 years onwards and has since been diagnosed with Ehlers-Danlos syndrome type IV (EDS IV). His particular mutation is predicted to result in lesser levels of normal collagen and may explain his favourable outcome from endovascular intervention. Understanding the genotype-phenotype correlation may influence the choice of therapy offered to patients with EDS IV.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19695909     DOI： 10.1016/j.ejvs.2009.07.009

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN： 1078-5884            Impact factor:   7.069


  4 in total

1.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

2.  Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.

Authors:  Gerd A Müller; Uwe Hansen; Zhi Xu; Benjamin Griswold; Mark I Talan; Nazli B McDonnell; Wilfried Briest
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

3.  Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.

Authors:  Wilfried Briest; Timothy K Cooper; Hyun-Jin Tae; Melissa Krawczyk; Nazli B McDonnell; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

4.  Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.

Authors:  Eline Overwater; Luisa Marsili; Marieke J H Baars; Annette F Baas; Irma van de Beek; Eelco Dulfer; Johanna M van Hagen; Yvonne Hilhorst-Hofstee; Marlies Kempers; Ingrid P Krapels; Leonie A Menke; Judith M A Verhagen; Kak K Yeung; Petra J G Zwijnenburg; Maarten Groenink; Peter van Rijn; Marjan M Weiss; Els Voorhoeve; J Peter van Tintelen; Arjan C Houweling; Alessandra Maugeri
Journal:  Hum Mutat       Date:  2018-07-12       Impact factor: 4.878
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.